Evidano is an AI-powered qualitative data analysis platform that helps researchers analyze interviews, open-ended surveys, and documents. According to the PLOS One study, trial unit staff describe safety reporting as a balancing act and identify training, clarity, and shared tools as practical solutions PLOS One. The primary keyword for this post is AI qualitative analysis for safety reporting, aimed at CTU managers, trial methodologists, and research operations teams seeking to convert qualitative insights into operational changes after the new UK clinical trials regulations that came into force on 28-Apr-2026. This post explains what the PLOS One study measured (23 participants across four focus groups), what those findings mean for trial workflows, and how AI-enabled qualitative research tools can accelerate synthesis, create shareable templates, and produce auditable evidence for regulators.
Key Takeaways
According to the PLOS One study, 23 CTU staff participated in four focus groups (01-July-2024 to 04-March-2025) and reported that safety reporting is experienced as "walking on a tightrope" between over-reporting and under-reporting PLOS One.
- 23 participants across four focus groups were included in the analysis conducted between 01-July-2024 and 04-March-2025, reported in PLOS One on 30-Jul-2026.
- Participants had a mean of 13.3 years working in trials (SD 9.5), reported in PLOS One, indicating experienced staff nevertheless face uncertainty about safety-reporting decisions.
- The PLOS One authors link their findings to the UK regulatory change that came into force on 28-Apr-2026, which reduced duplicative reporting to RECs according to the MHRA and UK legislation.
- The PLOS One study recommended clearer regulator guidance, role-specific training, and CTU-level knowledge sharing platforms as practical next steps.
What the PLOS One study found and how it was measured
The PLOS One study found that trial staff balance risk-proportionate reporting against risk-aversion, creating inefficiency and uncertainty.
According to PLOS One, the study used four online focus groups conducted between 01-July-2024 and 04-March-2025 with 23 participants from 10 of 52 UK registered CTUs, and data were analysed using Reflexive Thematic Analysis PLOS One.
PLOS One reported a central theme, "Walking on a tightrope: Making justifiable decisions, " and five subthemes: (1) uncertainty about consequences, (2) bureaucratic red tape, (3) competing demands, (4) lack of clarity and transparency, and (5) variable experience and training.
"Generally, you’ve got to balance what you need to collect in terms of safety reporting and in terms of what’s needed to monitor the safety of the drug, " said Participant 16 in the study (PLOS One).
"It feels difficult and there is always that element of anxiety that you’ve got it wrong, " said Participant 20 in PLOS One, which the authors link to conservative, time-consuming reporting practices that can obscure safety signals.
Findings Snapshot
| Date | Metric | Value | Implication |
|---|---|---|---|
| 30-Jul-2026 | Publication | PLOS One | Peer-reviewed qualitative evidence of CTU experiences with safety reporting |
| 01-Jul-2024 to 04-Mar-2025 | Data collection | 4 online focus groups, 23 participants | Rich qualitative data across 10 of 52 UK CTUs |
| Reported in PLOS One | Participant experience | Mean 13.3 years (SD 9.5) | Experienced staff still report uncertainty about decisions |
| 28-Apr-2026 | Regulatory change | MHRA Legislation enacted | Reduces duplicative reporting and codifies risk-proportionate categories |
Implications for CTU managers and trial methodologists
CTU managers should prioritise role-specific training, because the PLOS One study shows knowledge gaps and low confidence drive conservative reporting choices.
According to PLOS One, participants recommended shared templates, mentoring, and case studies to standardise practices and reduce duplication across sponsors and sites.
Regulatory alignment matters: the PLOS One authors link operational burden to inconsistent requirements across portals such as EudraVigilance and national forms, and note that the UK changes effective on 28-Apr-2026 reduce duplicate REC reporting (MHRA/legislation).
Embedding patient-reported outcome measures is recommended by ICH E6 (R3) 2025, and PLOS One highlights PROMs as one route to capture low‑grade toxicities that affect quality of life.
How Evidano Helps CTUs implement the study recommendations
Problem: Slow synthesis of qualitative findings
Solution: Evidano provides rapid thematic and cross-segment analysis to convert focus-group transcripts into prioritized themes and counts, enabling CTU managers to produce decision-ready summaries within days rather than weeks.
Evidano provides these features and more; see the platform details at Evidano Features.
Problem: Lack of standard templates and transparency
Solution: Evidano can auto-generate extractable quotes, coded excerpts, and audit trails from transcripts so CTUs can share standardised case-study templates and decision logs as recommended in PLOS One.
Evidano provides secure encryption and document-level provenance so shared templates are auditable for sponsors and regulators.
Problem: Training and experiential gaps
Solution: Evidano ingests transcripts, slide decks, and SOPs to build searchable knowledge bases and example-driven training modules, supporting the mentoring and observational learning solutions participants suggested in PLOS One.
Evidano also supports transcription and translation workflows to turn recorded focus groups into cleaned, pseudonymised data for reuse.
Problem: Need for regulator-ready evidence
Solution: Evidano creates exportable tables, quote packs, and visualizations (co-occurrence networks, hierarchical codes) that map staff concerns to specific regulatory changes such as the 28-Apr-2026 MHRA reforms and ICH E6 (R3), enabling CTUs to demonstrate step changes in efficiency and decision-making.
FAQ: AI qualitative analysis safety reporting
How can AI qualitative analysis speed safety-reporting improvements?
Answer: AI qualitative analysis accelerates synthesis by auto-coding transcripts, extracting verbatim quotes, and producing frequency tables that highlight recurring operational barriers.
According to PLOS One, CTU staff need shareable evidence and templates; AI outputs provide the structured evidence and examples participants requested for mentoring and regulator engagement.
Will AI replace human judgement in deciding what to report to regulators?
Answer: No, AI supports human decision-making by surfacing patterns and precedent, while final causality and safety decisions remain the responsibility of trial clinicians and sponsors.
The PLOS One study emphasises justifiable decision-making and argues that improved tools and training increase confidence; AI tools are tools to inform that confidence.
Can AI tools produce regulator-ready audit trails for safety-reporting changes?
Answer: Yes, AI-enabled platforms can generate exportable audit trails and coded evidence that match the transparency and traceability needs described in PLOS One.
Evidano produces exportable codebooks, timestamped exports, and quote lists that CTUs can attach to submissions or use in MHRA/HRA interactions.
What immediate steps should CTUs take after reading the PLOS One study?
Answer: Immediate steps are to collect recent focus-group or incident-review transcripts, run them through a thematic analysis workflow, and build a short set of templates and decision logs to trial with one protocol.
PLOS One recommends knowledge-sharing, mentoring, and role-specific training; AI-enabled synthesis makes those activities faster to initiate and repeat across trials.
Conclusion & Next Steps
The PLOS One study documents how 23 UK CTU staff describe safety reporting as a tightrope between over-reporting and under-reporting, and it recommends clearer guidance, training, and sharing platforms to restore balance PLOS One.
AI qualitative analysis for safety reporting turns focus-group insights into auditable, regulator-ready evidence, shortening the time from transcription to action and addressing the PLOS One recommendations for shareable templates and training.
If you manage trial operations or lead a CTU, try a focused pilot: run one recent focus group or SAE review through an AI-assisted thematic pipeline and export a decision log to test with sponsors and sites.
To get started, Try Evidano for free and see how thematic analysis, transcription, and exportable audit trails can help you implement the pragmatic, risk-proportionate reporting practices the PLOS One study calls for.